Western blot was used to determine the expression of the pro-fibrotic marker CTGF, and the PFD was found to inhibit the stimulation of TGF-β2, which markedly attenuated the expression of CTGF in RPE cells (Figure 5). The gene discussed is TGFB2; the disease is polyostotic fibrous dysplasia.